A detailed history of Black Rock Inc. transactions in Omeros Corp stock. As of the latest transaction made, Black Rock Inc. holds 4,101,584 shares of OMER stock, worth $24.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,101,584
Previous 4,211,122 2.6%
Holding current value
$24.7 Million
Previous $14.5 Million 14.62%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$3.04 - $4.23 $332,995 - $463,345
-109,538 Reduced 2.6%
4,101,584 $16.7 Million
Q1 2024

May 10, 2024

SELL
$2.88 - $4.89 $197,896 - $336,011
-68,714 Reduced 1.61%
4,211,122 $14.5 Million
Q4 2023

Feb 13, 2024

BUY
$1.08 - $3.63 $274,842 - $923,776
254,484 Added 6.32%
4,279,836 $14 Million
Q3 2023

Nov 13, 2023

SELL
$2.81 - $5.69 $364,176 - $737,424
-129,600 Reduced 3.12%
4,025,352 $11.8 Million
Q2 2023

Aug 11, 2023

BUY
$4.45 - $7.57 $13.3 Million - $22.7 Million
2,994,468 Added 258.04%
4,154,952 $22.6 Million
Q1 2023

May 12, 2023

BUY
$2.48 - $5.22 $52,952 - $111,457
21,352 Added 1.87%
1,160,484 $5.4 Million
Q4 2022

Feb 13, 2023

SELL
$1.75 - $3.96 $1,996 - $4,518
-1,141 Reduced 0.1%
1,139,132 $2.57 Million
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $269,667 - $651,041
-87,271 Reduced 7.11%
1,140,273 $3.59 Million
Q2 2022

Aug 12, 2022

SELL
$1.92 - $6.28 $5.45 Million - $17.8 Million
-2,837,857 Reduced 69.81%
1,227,544 $3.38 Million
Q1 2022

May 12, 2022

BUY
$5.07 - $7.2 $77,941 - $110,685
15,373 Added 0.38%
4,065,401 $24.4 Million
Q4 2021

Feb 10, 2022

SELL
$5.67 - $8.54 $2.7 Million - $4.06 Million
-475,472 Reduced 10.51%
4,050,028 $26 Million
Q3 2021

Nov 09, 2021

SELL
$13.4 - $16.3 $546,009 - $664,176
-40,747 Reduced 0.89%
4,525,500 $62.4 Million
Q2 2021

Aug 11, 2021

BUY
$14.81 - $19.13 $67.6 Million - $87.4 Million
4,566,247 New
4,566,247 $67.8 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $378M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.